Nexalin Technology Equity Warrants Exp 15th Sept 2025 NXLIW:NASDAQ

RT Quote | USD
Last | 05/09/24 EDT
0.12UNCH (UNCH)
Volume
14
52 week range
0.01 - 0.56
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.12
  • 52 Week High0.56
  • 52 Week High Date04/03/24
  • 52 Week Low0.01
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.12
  • 52 Week High0.56
  • 52 Week High Date04/03/24
  • 52 Week Low0.01
  • 52 Week Low Date10/31/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nexalin Technology Equity Warrants Exp 15th Sept 2025

 

Profile

MORE
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It also has...
Rick Morad
Independent Chairman of the Board
Mark White
President, Chief Executive Officer, Director
Address
26072 MERIT CIRCLE, SUITE 106
Laguna Niguel, CA
92653
United States